P. Goldsmith

发表

Effects of Pan- and Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists on Cortical Spreading Depression in the Rat: Therapeutic Potential for Migraine

M. James, N. Upton, M. Gunthorpe, 2007, Journal of Pharmacology and Experimental Therapeutics.

Effects of pan-and subtype-selective NMDA receptor antagonists on cortical spreading depression in the rat : therapeutic potential for migraine

N. Upton, M. Gunthorpe, M. Peeters, 2007 .

Complaints from patients with functional neurological disorders: a cross-sectional UK survey of why patients complain and the effect on the clinicians who look after them

P. Goldsmith, C. Bolton, 2018, BMJ Open.

A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia

J. Affinito, P. Goldsmith, A. Mahableshwarkar, 2019, Schizophrenia Research.

Azathioprine prescribing in neurology

G. Lennox, P. Goldsmith, N. Bhalla, 2008, Journal of Neurology.

The man who could not walk backward: An unusual presentation of neuroferritinopathy

S. Baker, Elizabeth R. Williams, M. Baker, 2011, Movement disorders : official journal of the Movement Disorder Society.

How good at neurology are you – Questions?

G. Lennox, P. Goldsmith, 2002, Practical Neurology.

How Good at Neurology are you? – Questions

G. Lennox, P. Goldsmith, 2002, Practical Neurology.

Adult‐Onset Alcohol Suppressible Cervical Dystonia: A Case Report

P. Goldsmith, Henry J Grantham, H. Grantham, 2015, Movement disorders clinical practice.

Two in the hand, an essential lesson in tremor management

N. Archibald, P. Goldsmith, D. Burn, 2010, Practical Neurology.

Roadmap to 2030 for Drug Evaluation in Older Adults

J. Gurwitz, M. Pirmohamed, B. Radziszewska, 2021, Clinical pharmacology and therapeutics.

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers

S. Neelakantham, V. Erpenbeck, M. Larbig, 2016, Clinical pharmacology in drug development.

The Status of Expectancy-Arousal Theory: Comparative Credibility of Systematic Desensitization and Rational-Emotive Therapy in the Treatment of Anxiety about Study

C. Dancey, W. Dryden, Peter Goldsmith, 1990, Psychological reports.

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

Baldur P Magnusson, T. Popov, S. Weinstein, 2016, Data in brief.

Extrinsic cerebral venous sinus obstruction resulting in intracranial hypertension

D. Burn, A. Coulthard, A. Jenkins, 1999, Postgraduate medical journal.

How Good at Neurology are you? – Answers

G. Lennox, P. Goldsmith, J. Ray, 2004, Practical Neurology.

Adult‐onset myoclonus ataxia associated with the mitochondrial m.8993T>C “NARP” mutation

D. Turnbull, M. Martikainen, D. Burn, 2015, Movement disorders : official journal of the Movement Disorder Society.

How Good at Neurology are you? – Answers

G. Lennox, P. Goldsmith, J. Ray, 2004, Practical Neurology.

Congenital diaphragmatic hernia causing cardiac arrest in a 30-year-old woman.

P. Goldsmith, P. Turner, Y. M. Goh, 2017, Annals of the Royal College of Surgeons of England.

Are these visual symptoms due to migraine? A guide for general practice.

P. Goldsmith, 2020, The British journal of general practice : the journal of the Royal College of General Practitioners.

A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects

P. Renshaw, D. Yurgelun-Todd, T. Uz, 2019, Psychopharmacology.

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.

Baldur P Magnusson, Todor A Popov, S. Weinstein, 2016, Pulmonary pharmacology & therapeutics.

A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events

J. Affinito, J. Xie, P. Goldsmith, 2017, Drugs in R&D.

Human clearance prediction: shifting the paradigm

Malcolm Rowland, Thierry Lavé, Kathryn Chapman, 2009, Expert opinion on drug metabolism & toxicology.

A pilot evaluation of an online cognitive behavioral therapy for insomnia disorder – targeted screening and interactive Web design lead to improved sleep in a community population

K. Anderson, P. Goldsmith, A. Gardiner, 2014, Nature and science of sleep.

QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study

Baldur P Magnusson, Todor A Popov, S. Miller, 2015 .

A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects

P. Renshaw, D. Yurgelun-Todd, T. Uz, 2019, Psychopharmacology.

A human [11C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor

Vladimir Stepanov, Akihiro Takano, Paul Goldsmith, 2016, NeuroImage.